BMRN — BioMarin Pharmaceutical Inc. stock price, charts and financials

QT53BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
63.94
-1.14-1.75%
BMRNQT53BioMarin Pharmaceutical Inc.·NASDAQ
63.94-1.75%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Sep 15, 20268-KCurrent report
Sep 14, 20264Statement of changes in beneficial ownership
Sep 14, 20268-KCurrent report
Sep 14, 20263Initial statement of beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Sep 01, 20268-KCurrent report
Aug 31, 20268-KCurrent report
Aug 18, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 202610-QQuarterly report
Jul 13, 20268-K/ACurrent report (amended)
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 05, 202610-QQuarterly report